Trial intelligence / Profile preview

Metformin and Lifestyle for Diabetes Prevention in Women with Prior GDM

NCT00265746Phase 4Withdrawn

Sponsor
Medical University of Lodz
Start
Nov 2005
Primary completion
Jan 2007
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Medical University of Lodz. Primary endpoint: Incidence of type 2 diabetes mellitus. Planned start Nov 2005; status: withdrawn.

02

Drugs

metformin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00265746.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00265746.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call